Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor
DBCAT005913Therapeutic category
A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of March 13, 2024
Which targets do Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account